The effectiveness of an immersive virtual reality and telemedicine-based cognitive intervention on prospective memory in Parkinson's disease patients with mild cognitive impairment and healthy aged individuals: design and preliminary baseline results of a placebo-controlled study.
Parkinson’s disease
healthy aging
immersive virtual reality
prospective memory
telemedicine
training
Journal
Frontiers in psychology
ISSN: 1664-1078
Titre abrégé: Front Psychol
Pays: Switzerland
ID NLM: 101550902
Informations de publication
Date de publication:
2023
2023
Historique:
received:
27
07
2023
accepted:
10
10
2023
medline:
6
11
2023
pubmed:
6
11
2023
entrez:
6
11
2023
Statut:
epublish
Résumé
Prospective memory (PM) impairments have been extensively documented in individuals with Parkinson's disease associated with mild cognitive impairment (PD-MCI) and in those with healthy aging. Considering how PM failure decreases individuals' quality of life and functional independence in the activities of daily living, training to enhance this ability could be a prior target of intervention. Here, we aimed to present the study protocol and preliminary results of a novel immersive virtual reality (IVR) and telemedicine-based (TM) cognitive intervention focused on executive abilities (i.e., planning, shifting, and updating) to improve PM functioning in PD-MCI patients and healthy elderly individuals. Outcome measures, collected before, immediately after and 2 months after the intervention, included: (1) pre-post training changes in objective cognitive functioning, evaluated with tests assessing executive functions and PM; (2) pre-post training changes in subjective perception of memory functioning, psychiatric symptoms, autonomy in daily living and quality of life, evaluated using the appropriate scales; (3) usability, feasibility and users' compliance with the proposed IVR and telemedicine program. The efficacy of this intervention compared to an active control condition is currently being evaluated in a randomized, double-blind controlled trial, which will be conducted on 30 eligible PD-MCI patients and 30 older adults. Preliminary results concerning between-group comparisons of demographic and neuropsychological screening data show a good balance among the intervention groups considered in this study. The results also suggest good levels of usability, feasibility and acceptability, thus supporting the notion that our intervention can be used to promote cognitive functioning, even in people with cognitive decline. Considering the relatively low costs and easy accessibility to this program, it could prove valuable in primary prevention initiatives and early cognitive rehabilitation for dementia risk reduction.
Identifiants
pubmed: 37928597
doi: 10.3389/fpsyg.2023.1268337
pmc: PMC10622796
doi:
Types de publication
Journal Article
Langues
eng
Pagination
1268337Informations de copyright
Copyright © 2023 De Simone, Costa, Tieri, Taglieri, Cona, Fiorenzato, Carlesimo, Caltagirone and Zabberoni.
Déclaration de conflit d'intérêts
MS, AC, GT, ST, GAC, CC, and SZ were employed by IRCCS Santa Lucia Foundation. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The author(s) declared that they were an editorial board member of Frontiers, at the time of submission. This had no impact on the peer review process and the final decision.
Références
J Int Neuropsychol Soc. 2018 Jul;24(6):640-645
pubmed: 29606153
Lancet Neurol. 2010 Dec;9(12):1200-1213
pubmed: 20880750
J Neurol Neurosurg Psychiatry. 2003 Jun;74(6):704-9
pubmed: 12754335
J Clin Exp Neuropsychol. 2011 Nov;33(9):982-8
pubmed: 22082081
Neurol Sci. 2013 Oct;34(10):1797-803
pubmed: 23479031
J Gen Psychol. 2008 Jan;135(1):4-22
pubmed: 18318405
Clin Neuropsychol. 2018 Jul;32(5):937-959
pubmed: 29183225
Dev Psychol. 2008 Mar;44(2):612-7
pubmed: 18331148
Memory. 2000 Sep;8(5):311-21
pubmed: 11045239
Trials. 2019 May 22;20(1):282
pubmed: 31118095
Neuropsychologia. 2011 Jul;49(8):2166-77
pubmed: 21255592
Neuropsychology. 2008 May;22(3):283-92
pubmed: 18444706
Arch Gen Psychiatry. 1961 Jun;4:561-71
pubmed: 13688369
J Neuroeng Rehabil. 2017 Feb 21;14(1):16
pubmed: 28222783
Arch Clin Neuropsychol. 2017 Nov 1;32(7):840-860
pubmed: 28961738
Ital J Neurol Sci. 1996 Aug;17(4):305-9
pubmed: 8915764
Brain. 2007 Jul;130(Pt 7):1787-98
pubmed: 17535834
Nat Rev Neurol. 2017 Apr;13(4):217-231
pubmed: 28257128
Neuropsychology. 2009 May;23(3):347-58
pubmed: 19413448
Neurol Sci. 2014 Mar;35(3):365-72
pubmed: 23963806
Gerontologist. 1969 Autumn;9(3):179-86
pubmed: 5349366
J Neurol Neurosurg Psychiatry. 2007 Nov;78(11):1191-8
pubmed: 17442762
Curr Protoc Neurosci. 2018 Jan 22;82:8.42.1-8.42.30
pubmed: 29357109
Expert Rev Med Devices. 2018 Feb;15(2):107-117
pubmed: 29313388
Psychiatry Res. 1991 Aug;38(2):143-62
pubmed: 1754629
JAMA Neurol. 2013 May;70(5):580-6
pubmed: 23529397
Neurol Sci. 2013 May;34(5):749-54
pubmed: 22689311
Int Rev Neurobiol. 2017;133:389-415
pubmed: 28802926
Neurol Sci. 2012 Oct;33(5):965-72
pubmed: 22262314
Neuropsychologia. 2012 Sep;50(11):2692-704
pubmed: 22841994
Eur Neurol. 1996;36(6):378-84
pubmed: 8954307
Curr Gerontol Geriatr Res. 2009;2009:298950
pubmed: 20168974
Nat Rev Neurosci. 2005 Apr;6(4):332-9
pubmed: 15803164
Neurology. 2015 Mar 17;84(11):1104-13
pubmed: 25681454
Neurorehabil Neural Repair. 2017 May;31(5):451-461
pubmed: 28176547
Psychol Med. 2023 Jun;53(8):3661-3671
pubmed: 35257646
Parkinsonism Relat Disord. 2016 Jan;22 Suppl 1:S144-8
pubmed: 26411499
J Clin Exp Neuropsychol. 1994 Dec;16(6):840-50
pubmed: 7890819
Ital J Neurol Sci. 1998 Jun;19(3):161-70
pubmed: 10933471
Psychol Res. 2014 Nov;78(6):892-904
pubmed: 24744122
Parkinsonism Relat Disord. 2019 Sep;66:51-55
pubmed: 31279634
Mov Disord. 2012 Mar;27(3):349-56
pubmed: 22275317
Mov Disord. 2018 Apr;33(4):520-527
pubmed: 29573469